|
Originally published In Press as doi:10.1074/jbc.M301364200 on May 20, 2003
J. Biol. Chem., Vol. 278, Issue 30, 27772-27780, July 25, 2003
Activation of the p70 S6 Kinase and Phosphorylation of the 4E-BP1 Repressor of mRNA Translation by Type I Interferons*
Fatima Lekmine a b,
Shahab Uddin a b c,
Antonella Sassano a,
Simrit Parmar a,
Saskia M. Brachmann d e f,
Beata Majchrzak g,
Nahum Sonenberg h,
Nissim Hay i,
Eleanor N. Fish g and
Leonidas C. Platanias a j
From the
aRobert H. Lurie Comprehensive Cancer Center and
Division of Hematology-Oncology, Northwestern University Medical School and
Lakeside Veterans Administration Medical Center, Chicago, Illinois 60611, the
cSection of Hematology-Oncology, University of
Chicago, Chicago, Illinois 60637, the gDivision of
Cell & Molecular Biology, Toronto Research Institute, University Health,
Network and Department of Immunology, University of Toronto, Toronto, Ontario
M5S 3E2, Canada, the dDivision of Signal Transduction,
Beth Israel Medical Center, Harvard Medical School, Boston, Massachusetts
02115, the eInstitut fuer Biochemie, Freie
Universitaet Berlin, Berlin 14195, Germany, the
hDepartment of Biochemistry, McGill University,
Montreal, Quebec H3G 1Y6, Canada, and the iDepartment
of Molecular Genetics, University of Illinois, Chicago, Illinois 60607
The Type I IFN receptor-generated signals required for initiation of mRNA
translation and, ultimately, induction of protein products that mediate IFN
responses, remain unknown. We have previously shown that IFN and
IFN induce phosphorylation of insulin receptor substrate proteins and
downstream engagement of the phosphatidylinositol (PI) 3'-kinase
pathway. In the present study we provide evidence for the existence of a Type
I IFN-dependent signaling cascade activated downstream of PI 3'-kinase,
involving p70 S6 kinase. Our data demonstrate that p70 S6K is rapidly
phosphorylated on threonine 421 and serine 424 and is activated during
treatment of cells with IFN or IFN . Such activation of p70 S6K is
blocked by pharmacological inhibitors of the PI 3'-kinase or the FKBP
12-rapamycin-associated protein/mammalian target of rapamycin (FRAP/mTOR).
Consistent with this, the Type I IFN-dependent phosphorylation/activation of
p70 S6K is defective in embryonic fibroblasts from mice with targeted
disruption of the p85 and p85 subunits of the PI 3'-kinase
(p85 / /). Treatment of sensitive cell
lines with IFN or IFN also results in
phosphorylation/inactivation of the 4E-BP-1 repressor of mRNA translation.
Such 4E-BP1 phosphorylation is also PI3'-kinase-dependent and
rapamycin-sensitive, indicating that the Type I IFN-inducible activation of
PI3'-kinase and FRAP/mTOR results in dissociation of 4E-BP1 from the
eukaryotic initiation factor-4E (eIF4E) complex. Altogether, our data
establish that the Type I IFN receptor-activated PI 3'-kinase pathway
mediates activation of the p70 S6 kinase and inactivation of 4E-BP1, to
regulate mRNA translation and induction of Type I IFN responses.
Received for publication, February 7, 2003
, and in revised form, May 13, 2003.
* This work was supported in part by National Institutes of Health Grants
CA77816 and CA94079 (to L. C. P.), a Merit review grant from the Department of
Veterans Affairs (to L. C. P.), and Canadian Institutes for Health Research
Grant MOP-15094 (to E. N. F.). The costs of publication of this article were
defrayed in part by the payment of page charges. This article must therefore
be hereby marked "advertisement" in accordance with 18
U.S.C. Section 1734 solely to indicate this fact.
b Both authors contributed equally to this work and are first co-authors.
f Recipient of a fellowship from Boehringer Ingelheim Funds.
j
To whom correspondence should be addressed: Robert H. Lurie Comprehensive
Cancer Center, Northwestern University Medical School, 710 North Fairbanks
St., Olson 8250, Chicago, IL 60611. Tel.: 312-503-4267; Fax: 312-908-1372;
E-mail:
l-platanias{at}northwestern.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Kroczynska, S. Kaur, E. Katsoulidis, B. Majchrzak-Kita, A. Sassano, S. C. Kozma, E. N. Fish, and L. C. Platanias
Interferon-Dependent Engagement of Eukaryotic Initiation Factor 4B via S6 Kinase (S6K)- and Ribosomal Protein S6K-Mediated Signals
Mol. Cell. Biol.,
May 15, 2009;
29(10):
2865 - 2875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Redig, A. Sassano, B. Majchrzak-Kita, E. Katsoulidis, H. Liu, J. K. Altman, E. N. Fish, A. Wickrema, and L. C. Platanias
Activation of Protein Kinase C{eta} by Type I Interferons
J. Biol. Chem.,
April 17, 2009;
284(16):
10301 - 10314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Minhajuddin, K. M. Bijli, F. Fazal, A. Sassano, K. I. Nakayama, N. Hay, L. C. Platanias, and A. Rahman
Protein Kinase C-{delta} and Phosphatidylinositol 3-Kinase/Akt Activate Mammalian Target of Rapamycin to Modulate NF-{kappa}B Activation and Intercellular Adhesion Molecule-1 (ICAM-1) Expression in Endothelial Cells
J. Biol. Chem.,
February 13, 2009;
284(7):
4052 - 4061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaur, A. Sassano, A. M. Joseph, B. Majchrzak-Kita, E. A. Eklund, A. Verma, S. M. Brachmann, E. N. Fish, and L. C. Platanias
Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling
J. Immunol.,
November 15, 2008;
181(10):
7316 - 7323.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Katsoulidis, A. Sassano, B. Majchrzak-Kita, N. Carayol, P. Yoon, A. Jordan, B. J. Druker, E. N. Fish, and L. C. Platanias
Suppression of Interferon (IFN)-inducible Genes and IFN-mediated Functional Responses in BCR-ABL-expressing Cells
J. Biol. Chem.,
April 18, 2008;
283(16):
10793 - 10803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaur, A. Sassano, B. Dolniak, S. Joshi, B. Majchrzak-Kita, D. P. Baker, N. Hay, E. N. Fish, and L. C. Platanias
Role of the Akt pathway in mRNA translation of interferon-stimulated genes
PNAS,
March 25, 2008;
105(12):
4808 - 4813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Maya-Monteiro, P. E. Almeida, H. D'Avila, A. S. Martins, A. P. Rezende, H. Castro-Faria-Neto, and P. T. Bozza
Leptin Induces Macrophage Lipid Body Formation by a Phosphatidylinositol 3-Kinase- and Mammalian Target of Rapamycin-dependent Mechanism
J. Biol. Chem.,
January 25, 2008;
283(4):
2203 - 2210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Altman, P. Yoon, E. Katsoulidis, B. Kroczynska, A. Sassano, A. J. Redig, H. Glaser, A. Jordan, M. S. Tallman, N. Hay, et al.
Regulatory Effects of Mammalian Target of Rapamycin-mediated Signals in the Generation of Arsenic Trioxide Responses
J. Biol. Chem.,
January 25, 2008;
283(4):
1992 - 2001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kazemi, Z. Mounir, D. Baltzis, J. F. Raven, S. Wang, J.-L. Krishnamoorthy, O. Pluquet, J. Pelletier, and A. E. Koromilas
A Novel Function of eIF2{alpha} Kinases as Inducers of the Phosphoinositide-3 Kinase Signaling Pathway
Mol. Biol. Cell,
September 1, 2007;
18(9):
3635 - 3644.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kaur, L. Lal, A. Sassano, B. Majchrzak-Kita, M. Srikanth, D. P. Baker, E. Petroulakis, N. Hay, N. Sonenberg, E. N. Fish, et al.
Regulatory Effects of Mammalian Target of Rapamycin-activated Pathways in Type I and II Interferon Signaling
J. Biol. Chem.,
January 19, 2007;
282(3):
1757 - 1768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ozpolat, U. Akar, M. Steiner, I. Zorrilla-Calancha, M. Tirado-Gomez, N. Colburn, M. Danilenko, S. Kornblau, and G. Lopez Berestein
Programmed Cell Death-4 Tumor Suppressor Protein Contributes to Retinoic Acid-Induced Terminal Granulocytic Differentiation of Human Myeloid Leukemia Cells
Mol. Cancer Res.,
January 1, 2007;
5(1):
95 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Yoon, N. Giafis, J. Smith, H. Mears, E. Katsoulidis, A. Sassano, J. Altman, A. J. Redig, M. S. Tallman, and L. C. Platanias
Activation of mammalian target of rapamycin and the p70 S6 kinase by arsenic trioxide in BCR-ABL-expressing cells.
Mol. Cancer Ther.,
November 1, 2006;
5(11):
2815 - 2823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Benkirane, F. Amiri, Q. N. Diep, M. El Mabrouk, and E. L. Schiffrin
PPAR-{gamma} inhibits ANG II-induced cell growth via SHIP2 and 4E-BP1
Am J Physiol Heart Circ Physiol,
January 1, 2006;
290(1):
H390 - H397.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Benkirane, E. C. Viel, F. Amiri, and E. L. Schiffrin
Peroxisome Proliferator-Activated Receptor {gamma} Regulates Angiotensin II-Stimulated Phosphatidylinositol 3-Kinase and Mitogen-Activated Protein Kinase in Blood Vessels In Vivo
Hypertension,
January 1, 2006;
47(1):
102 - 108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Parmar, J. Smith, A. Sassano, S. Uddin, E. Katsoulidis, B. Majchrzak, S. Kambhampati, E. A. Eklund, M. S. Tallman, E. N. Fish, et al.
Differential regulation of the p70 S6 kinase pathway by interferon {alpha} (IFN{alpha}) and imatinib mesylate (STI571) in chronic myelogenous leukemia cells
Blood,
October 1, 2005;
106(7):
2436 - 2443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, S. Batra, A. Sassano, B. Majchrzak, D. E. Levy, M. Gaestel, E. N. Fish, R. J. Davis, and L. C. Platanias
Activation of Mitogen-activated Protein Kinase Kinase (MKK) 3 and MKK6 by Type I Interferons
J. Biol. Chem.,
March 18, 2005;
280(11):
10001 - 10010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Lal, Y. Li, J. Smith, A. Sassano, S. Uddin, S. Parmar, M. S. Tallman, S. Minucci, N. Hay, and L. C. Platanias
Activation of the p70 S6 kinase by all-trans-retinoic acid in acute promyelocytic leukemia cells
Blood,
February 15, 2005;
105(4):
1669 - 1677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. D. Ryman, K. C. Meier, E. M. Nangle, S. L. Ragsdale, N. L. Korneeva, R. E. Rhoads, M. R. MacDonald, and W. B. Klimstra
Sindbis Virus Translation Is Inhibited by a PKR/RNase L-Independent Effector Induced by Alpha/Beta Interferon Priming of Dendritic Cells
J. Virol.,
February 1, 2005;
79(3):
1487 - 1499.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Fimia, C. Evangelisti, T. Alonzi, M. Romani, F. Fratini, G. Paonessa, G. Ippolito, M. Tripodi, and M. Piacentini
Conventional Protein Kinase C Inhibition Prevents Alpha Interferon-Mediated Hepatitis C Virus Replicon Clearance by Impairing STAT Activation
J. Virol.,
December 1, 2004;
78(23):
12809 - 12816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Srivastava, S. Batra, A. Sassano, Y. Li, B. Majchrzak, H. Kiyokawa, A. Altman, E. N. Fish, and L. C. Platanias
Engagement of Protein Kinase C-{theta} in Interferon Signaling in T-cells
J. Biol. Chem.,
July 16, 2004;
279(29):
29911 - 29920.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Thyrell, L. Hjortsberg, V. Arulampalam, T. Panaretakis, S. Uhles, M. Dagnell, B. Zhivotovsky, I. Leibiger, D. Grander, and K. Pokrovskaja
Interferon {alpha}-induced Apoptosis in Tumor Cells Is Mediated through the Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Signaling Pathway
J. Biol. Chem.,
June 4, 2004;
279(23):
24152 - 24162.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, A. Sassano, B. Majchrzak, D. K. Deb, D. E. Levy, M. Gaestel, A. R. Nebreda, E. N. Fish, and L. C. Platanias
Role of p38{alpha} Map Kinase in Type I Interferon Signaling
J. Biol. Chem.,
January 9, 2004;
279(2):
970 - 979.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|